Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Drug Discovery Today
|
November 19, 2013
Antibody-drug conjugates: current status and future directions
Heidi L Perez, Pina M Cardarelli, Shrikant Deshpande, et al.
SLAS Technology
|
July 3, 2025
Development and application of a customized online affinity selection mass spectrometry screening platform
Jun Zhang, Jerry Barney, Qingqing Shen, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 4, 2014
Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists
Kyoung Soon Kim, Liping Zhang, David Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
Andrew F Donnell, Yong Zhang, Erik M Stang, et al.
Analytical Chemistry
|
August 21, 2025
An Ultra-High Throughput Cell-Based Mass Spectrometry Flux Assay as a Pathway-Selective In Situ Screening Approach
Daniel P Downes, Christopher M Barbieri, David Connors, et al.
Organic Letters
|
June 7, 2023
Synthesis of Bicyclo[1.1.0]butanes from Iodo-Bicyclo[1.1.1]pentanes
Michael D Mandler, James Mignone, Elizabeth A Jurica, et al.
Journal of Medicinal Chemistry
|
January 14, 2015
Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity
Heidi L Perez, Charu Chaudhry, Stuart L Emanuel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
Heidi L Perez, Patrizia Banfi, Jay Bertrand, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists
Gretchen M Schroeder, Donna Wei, Patrizia Banfi, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Drug Discovery Today
|
November 19, 2013
Antibody-drug conjugates: current status and future directions
Heidi L Perez, Pina M Cardarelli, Shrikant Deshpande, et al.
SLAS Technology
|
July 3, 2025
Development and application of a customized online affinity selection mass spectrometry screening platform
Jun Zhang, Jerry Barney, Qingqing Shen, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 4, 2014
Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists
Kyoung Soon Kim, Liping Zhang, David Williams, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
Andrew F Donnell, Yong Zhang, Erik M Stang, et al.
Analytical Chemistry
|
August 21, 2025
An Ultra-High Throughput Cell-Based Mass Spectrometry Flux Assay as a Pathway-Selective In Situ Screening Approach
Daniel P Downes, Christopher M Barbieri, David Connors, et al.
Organic Letters
|
June 7, 2023
Synthesis of Bicyclo[1.1.0]butanes from Iodo-Bicyclo[1.1.1]pentanes
Michael D Mandler, James Mignone, Elizabeth A Jurica, et al.
Journal of Medicinal Chemistry
|
January 14, 2015
Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity
Heidi L Perez, Charu Chaudhry, Stuart L Emanuel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
Heidi L Perez, Patrizia Banfi, Jay Bertrand, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists
Gretchen M Schroeder, Donna Wei, Patrizia Banfi, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Page
of 1